Use of rituximab in pemphigus vulgaris/foliaceus patients during COVID-19 pandemic
- 2022, Volume 80 - Number 4
- Published: December 10, 2022
Use of rituximab in pemphigus vulgaris/foliaceus patients during COVID-19 pandemic
Inês Aparício-Martins 1 
, Joana Cabete 2
1 Department of Dermatology and Venereology, Unidade Local de Saúde de São José, Alameda Santo António dos Capuchos, Lisbon, Portugal; 2 Department of Dermatology and Venereology, Hospital de Santo António dos Capuchos, Unidade Local de Saúde São José; Department of Dermatology and Venereology, NOVA Medical School, Faculdade de Ciências Médicas; Centro Clínico Académico de Lisboa. Lisboa, Portugal
Inês Aparício-Martins, Joana Cabete
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: Inês Aparício-Martins. Email: inesapariciomartins@gmail.com
Abstract
Full content available in the PDF
